Sustainability & Climate

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

Chaim Indig’s third honor as a Top 50 CEO underscores Phreesia's deep impact on patient care, backed by major growth and market leadership.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

With a strong cash position, Arcus Biosciences heads into a pivotal year as investors await critical data on its promising cancer and autoimmune pipeline.

The nation's largest private bank is expanding its Oklahoma City campus, acquiring a former energy building in a move that signals local faith and national ambition.

Mizuho Americas and Pursuit launch the AI Nonprofit Build Corps, a new program training diverse talent to bring critical AI skills to NYC's social sector.

Vynleads launches its Done With Diabetes app, using AI for daily support. But can it stand out in a crowded market and reverse its financial fortunes?

Maureen Keough takes the helm at Solstice Environmental, bringing diverse tech and energy expertise to steer the firm through a new era of strategic growth.

Hoag becomes the world's first Center of Excellence in Oncoplastic Surgery, a revolutionary approach merging cancer removal with cosmetic preservation.

Facing a national crisis of long waits for autism diagnosis, a new free online tool from Catalight hopes to connect families with care in days, not months.

Iveco Group shareholders will decide the fate of its defence unit: a €1.7B sale to Leonardo with a huge dividend, or a spin-off into a new public company.

The hospitality giant redefines luxury with an unprecedented seven Five-Star hotels under one roof, cementing Macao's status as a top global destination.

The energy giant's dividend increase to $1.27 reflects robust financial health, strategic pivots to renewables, and a strong commitment to shareholders.

The rail giant's acquisition of the Swedish coupler leader signals a major strategic push into the global passenger transit market. Here's what it means.

A 'world-first' cervical implant from Zavation Medical Products combines two materials to enhance bone growth while maintaining critical imaging capabilities.

As Valentine's and Family Day approach, MADD Canada's new campaign confronts a rise in risky behaviour and a decline in public concern over impaired driving.

A non-invasive device for spinal cord injury gains major international praise, signaling a shift in neurorehabilitation and a path to market.

Australian biotech Amplia Therapeutics is bringing its promising pancreatic cancer trial to the US, a key step in developing a drug that targets the disease's defenses.

As North Carolina's population booms, a new partnership aims to expand access to cutting-edge fertility care, research, and education across the state.

After a decade-long battle with Stage 4 cancer, one patient's cure spotlights a revolutionary immunotherapy and its potential to change cancer treatment.